Clinical trial
Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs…
NCT00367822 · Axxonis Pharma AG, Industry · Completed
Key facts
| NCT number | NCT00367822 |
|---|---|
| Title | Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS) |
| Official title | Transdermal Lisuride: a Double-blind, Randomized, Active- and Placebo-controlled Multi-centre Phase III Efficacy Trial for the Treatment of Patients With Restless Legs Syndrome (RLS) |
| Lead sponsor | Axxonis Pharma AG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | Lisuride, Ropinirole, Placebo |
| Enrollment | 300 |
| First posted | Aug 23, 2006 |
| Last update posted | Mar 7, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: